VMP 22088011000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
BNF code 050301000BBACA0
Virtual Therapeutic Moiety Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil
Abbreviated name Elvitegravir 150mg/Cobicistat/Emtr/Tenofovir disoproxil tab
Basis of preferred name Other
Date of name applicability 2 Apr 2025
Previous name Generic Stribild 150mg/150mg/200mg/245mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Cobicistat
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 150.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Elvitegravir
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 150.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Emtricitabine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Tenofovir disoproxil
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 245.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Stribild 150mg/150mg/200mg/245mg tablets (Gilead Sciences Ltd)
Virtual Medicinal Product Packs
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.

Feedback